OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DCWL55

DCW Ltd

Commodity ChemicalsVerified

DCW Ltd's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no mention of going-concern language in the source documents. The company's valuation snapshot is also not available, making it difficult to assess its liquidity position relative to industry peers. Profitability metrics for DCW Ltd are weak compared to industry norms. The company reported a net income of INR 67.28 million on revenue of INR 4.995 billion, yielding a net margin of approximately 1.35%. This is significantly below the median net margin for the Commodity Chemicals industry, which typically exceeds 5%. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes, particularly in India where the company is based. Growth trajectory for DCW Ltd is uncertain. The company's recent financial performance shows a decline in operating income, which fell to INR 206.17 million from higher levels in prior periods. Without clear guidance on future revenue growth or cost management, the company's ability to expand its market share remains questionable. Risk factors for DCW Ltd include liquidity uncertainty and the absence of a clear capital structure. The company has not disclosed any recent equity or debt offerings, and there is no indication of dilution risk in the near term. However, the lack of balance-sheet data makes it difficult to assess the company's ability to meet short-term obligations. Recent events for DCW Ltd are limited to standard financial reporting. The company has not disclosed any material developments in its operations or strategy in the latest filings. There are no notable transcripts or press releases indicating significant changes in business direction or market positioning.

30-day price · DCWL+5.82 (+14.1%)
Low$37.11High$53.50Close$46.99As of12 May, 00:00 UTC
Profile
CompanyDCW Ltd
TickerDCWL.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. DCW Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily serving industrial and agricultural markets.

Classification. DCW Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

DCW Ltd's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no mention of going-concern language in the source documents. The company's valuation snapshot is also not available, making it difficult to assess its liquidity position relative to industry peers. Profitability metrics for DCW Ltd are weak compared to industry norms. The company reported a net income of INR 67.28 million on revenue of INR 4.995 billion, yielding a net margin of approximately 1.35%. This is significantly below the median net margin for the Commodity Chemicals industry, which typically exceeds 5%. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes, particularly in India where the company is based. Growth trajectory for DCW Ltd is uncertain. The company's recent financial performance shows a decline in operating income, which fell to INR 206.17 million from higher levels in prior periods. Without clear guidance on future revenue growth or cost management, the company's ability to expand its market share remains questionable. Risk factors for DCW Ltd include liquidity uncertainty and the absence of a clear capital structure. The company has not disclosed any recent equity or debt offerings, and there is no indication of dilution risk in the near term. However, the lack of balance-sheet data makes it difficult to assess the company's ability to meet short-term obligations. Recent events for DCW Ltd are limited to standard financial reporting. The company has not disclosed any material developments in its operations or strategy in the latest filings. There are no notable transcripts or press releases indicating significant changes in business direction or market positioning.
Key takeaways
  • DCW Ltd's net margin of 1.35% is significantly below the industry median for Commodity Chemicals.
  • The company's liquidity position and capital structure are not disclosed, raising concerns about financial transparency.
  • Revenue is concentrated in a single business segment with no geographic diversification.
  • Growth prospects are unclear due to declining operating income and lack of strategic guidance.
  • Dilution risk is currently low, but liquidity risk remains unassessed.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$5.00B
Gross profit$2.35B
Operating income$206.2M
Net income$67.3M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$24.55B$2.62B$1.08B$1.57B
FY-3$26.34B$3.52B$1.92B$1.96B
FY-2$18.72B$834.8M$156.6M$158.6M
FY-1$20.00B$933.0M$300.7M$535.2M
FY0$21.44B$1.18B$481.7M$588.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$19.03B$8.02B
FY-3$20.63B$10.25B
FY-2$20.89B$10.32B
FY-1$21.78B$10.33B$2.04B
FY0$20.89B$10.75B$1.99B
PeriodOCFCapExFCFSBC
FY-4$1.78B-$384.5M$1.57B
FY-3$2.26B-$862.1M$1.96B
FY-2$2.52B-$936.0M$158.6M
FY-1$1.91B-$764.8M$535.2M
FY0$2.78B-$931.2M$588.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$5.00B$206.2M$67.3M
FQ-6$4.89B$105.9M-$12.5M
FQ-5$4.74B$317.0M$134.2M
FQ-4$5.38B$304.8M$112.6M
FQ-3$4.75B$287.1M$113.9M
FQ-2$5.39B$319.7M$138.1M
FQ-1$5.20B$189.0M$49.0M
FQ0$6.09B$381.6M$180.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6$21.89B$10.37B$1.74B
FQ-5
FQ-4$21.78B$10.33B$2.04B
FQ-3
FQ-2$22.11B$10.58B$1.94B
FQ-1
FQ0$20.89B$10.75B$1.99B
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$668.2M-$159.8M
FQ-5
FQ-4$1.91B-$764.8M
FQ-3
FQ-2$1.30B-$547.6M
FQ-1
FQ0$2.78B-$931.2M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricDCWLActivity
Op margin4.1%5.5% medp25 -0.0% · p75 10.8%below median
Net margin1.3%4.1% medp25 0.1% · p75 8.8%below median
Gross margin47.1%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 02:03 UTC#4a67bf5d
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 18:15 UTCJob: 8bc1437c